Literature DB >> 8845606

Clinical and prognostic characteristics of papillary clear carcinoma of stomach.

K Uefuji1, T Ichikura, S Tamakuma.   

Abstract

Papillary clear carcinoma (PCC), a variant of gastric papillary adenocarcinoma, demonstrates the histologic features of cancer cells with clear cytoplasm and no nuclear polarity, resembling the primitive gut epithelium of the fetus. To clarify the clinical and prognostic characteristics of PCC, we examined operative specimens from 73 patients with gastric papillary adenocarcinoma. Light microscopic examination of hematoxylin and eosin (H&E) stained sections of specimens from 15 patients revealed the features of PCC. The patients with PCC demonstrated a higher incidence of Type 3 gross appearance, tumor invasion into the muscularis propria or beyond, involvement of distal lymph nodes, liver metastasis, elevated serum AFP concentrations, and palliative resections. In two subsets of patients who underwent curative resections of tumors invading the muscularis propria or beyond, those with PCC were found to have a significantly lower survival rate than those with other types of papillary adenocarcinoma (P < 0.05). PCC histology was a significant prognostic determinant according to multivariate analysis with the Cox proportional hazards model. We conclude that this subclassification of papillary adenocarcinoma, based on the cellular findings, is a useful prognostic indicator, and that intensive adjuvant therapy may be indicated for patients with the features of PCC, even if they have undergone curative resections.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8845606     DOI: 10.1007/bf00311499

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  19 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  Gastric carcinoma. A pathobiological classification.

Authors:  S C Ming
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

3.  Histologic and immunohistochemical studies of alpha-fetoprotein (AFP)-producing gastric carcinoma.

Authors:  S Koyama; T Ebihara; T Osuga
Journal:  Gastroenterol Jpn       Date:  1987-08

4.  Alpha-fetoprotein-producing renal cell carcinoma.

Authors:  H Morimoto; N Tanigawa; H Inoue; R Muraoka; Y Hosokawa; T Hattori
Journal:  Cancer       Date:  1988-01-01       Impact factor: 6.860

5.  High incidence of liver metastasis in gastric cancer with medullary growth pattern.

Authors:  N Kaibara; O Kimura; H Nishidoi; M Makino; H Kawasumi; S Koga
Journal:  J Surg Oncol       Date:  1985-03       Impact factor: 3.454

6.  Alpha-fetoprotein-producing gastric carcinoma with enteroblastic differentiation.

Authors:  H Matsunou; F Konishi; R E Jalal; N Yamamichi; A Mukawa
Journal:  Cancer       Date:  1994-02-01       Impact factor: 6.860

7.  Production of alpha-fetoprotein, normal serum proteins, and human chorionic gonadotropin in stomach cancer: histologic and immunohistochemical analyses of 35 cases.

Authors:  T Kodama; T Kameya; T Hirota; Y Shimosato; H Ohkura; T Mukojima; H Kitaoka
Journal:  Cancer       Date:  1981-10-01       Impact factor: 6.860

8.  An AFP-producing gastric carcinoma with features of hepatic differentiation. A case report.

Authors:  H Ishikura; Y Fukasawa; K Ogasawara; T Natori; Y Tsukada; M Aizawa
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

9.  Clinicopathological analysis of the intestinal type and diffuse type of gastric carcinoma.

Authors:  S Noda; K Soejima; K Inokuchi
Journal:  Jpn J Surg       Date:  1980-12

Review 10.  Hepatoid carcinoma of the stomach.

Authors:  A deLorimier; F Park; G V Aranha; C Reyes
Journal:  Cancer       Date:  1993-01-15       Impact factor: 6.860

View more
  5 in total

1.  Endoscopic submucosal dissection for papillary adenocarcinoma of the stomach: is it really safe?

Authors:  Hyun Jung Lee; Gwang Ha Kim; Do Youn Park; Young Keum Kim; Hye Kyung Jeon; Bong Eun Lee; Geun Am Song
Journal:  Gastric Cancer       Date:  2017-03-07       Impact factor: 7.370

2.  Is endoscopic submucosal dissection safe for papillary adenocarcinoma of the stomach?

Authors:  Hyun Jeong Lee; Gwang Ha Kim; Do Youn Park; Bong Eun Lee; Hye Kyung Jeon; Joon Hyung Jhi; Geun Am Song
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

3.  The vessels within epithelial circle (VEC) pattern as visualized by magnifying endoscopy with narrow-band imaging (ME-NBI) is a useful marker for the diagnosis of papillary adenocarcinoma: a case-controlled study.

Authors:  Takao Kanemitsu; Kenshi Yao; Takashi Nagahama; Shoko Fujiwara; Yasuhiro Takaki; Yoichiro Ono; Yu Matsushima; Toshiyuki Matsui; Hiroshi Tanabe; Atsuko Ota; Akinori Iwashita
Journal:  Gastric Cancer       Date:  2013-09-15       Impact factor: 7.370

4.  Efficacy and safety of endoscopic submucosal dissection for papillary adenocarcinoma-type early gastric cancer.

Authors:  Jae Ho Park; Ju Seok Kim; Sun Hyung Kang; Hee Seok Moon; Jae Kyu Sung; Hyun Yong Jeong
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

Review 5.  Endoscopic submucosal dissection of papillary adenocarcinoma of stomach; protocol for a systematic review and meta-analysis.

Authors:  Chang Seok Bang; Jae Ho Choi; Jae Jun Lee; Gwang Ho Baik
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.